Related Experiment Video
Updated: Mar 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
A Digital Health System to Assist Family Physicians to Safely Prescribe NOAC Medications
Samina Raza Abidi1, Jafna Cox2, Ashraf Abusharekh3
1Medical Informatics, Faculty of Medicine, Dalhousie University.
Abstract:
Atrial Fibrillation (AF) is the most common cardiac arrhythmia. Generally, the therapeutic options for managing AF include the use of anticoagulant drugs that prevent the coagulation of blood. New Oral Anticoagulants (NOACs) are not optimally prescribed to patients, despite their efficacy. In Canada, NOAC medications are not directly available to patients who belong to provincial benefits programs, rather a NOAC special authorization process establishes the eligibility of a patient to receive a NOAC and be paid by the provincial Pharmacare program. This special authorization process is tedious and paper-based which inhibits physicians to prescribe NOAC leading to suboptimal AF care to patients. In this paper, we present a computerized NOAC Authorization Decision Support System (NOAC-ADSS), accessible to physicians to help them (a) determine a patient eligibility for NOAC based on Canadian AF clinical guidelines, and (b) complete the special authorization form. We present a semantic web based system to ontologically model the NOAC eligibility criteria and execute the knowledge to determine a patient NOAC eligibility and dosage.
Insights
Physicians can now use a new system to easily determine patient eligibility for New Oral Anticoagulants (NOACs) for atrial fibrillation (AF). This tool simplifies the special authorization process, improving patient care.
Area of Science:
- Cardiology
- Health Informatics
- Medical Decision Support
Background:
- Atrial Fibrillation (AF) is a prevalent cardiac arrhythmia.
- Current anticoagulant therapies, including New Oral Anticoagulants (NOACs), are underutilized due to complex prescription processes.
- Canada's provincial Pharmacare programs require a tedious, paper-based special authorization for NOACs, hindering optimal AF management.
Purpose of the Study:
- To develop a computerized system to aid physicians in prescribing NOACs for AF.
- To streamline the NOAC special authorization process for patients in Canadian provincial benefits programs.
- To improve the quality of AF care by facilitating NOAC access.
Main Methods:
- Development of a NOAC Authorization Decision Support System (NOAC-ADSS).
- Utilizing semantic web technologies and ontologies to model NOAC eligibility criteria.
- Implementing a system to execute knowledge for determining patient eligibility and dosage.
Main Results:
- The NOAC-ADSS provides physicians with a tool to assess patient eligibility for NOACs based on Canadian AF guidelines.
- The system assists in completing the special authorization form, reducing administrative burden.
- Ontological modeling enables accurate and efficient determination of NOAC eligibility and dosage.
Conclusions:
- The NOAC-ADSS offers a practical solution to the challenges in prescribing NOACs for AF patients.
- This system has the potential to optimize AF care by improving access to effective anticoagulant therapy.
- Digitalizing the authorization process can significantly enhance physician efficiency and patient outcomes.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Oral Drug Delivery Systems: Continuous-Release Systems

